2010 - 2011 Stem Cell Symposium
induced Pluripotent Stem Cells (iPSCs)
Thursday, December 2, 2010
9:00 am – 5:00 pm
SLU Administration Building Auditorium
South Lake Union Campus, 815 Mercer Street
Symposium flyer
Symposium schedule
Poster list
Schedule of Talks:
All Talks take place in the Orin Smith Auditorium
9:00 – 10:30 Session 1
Creating Developmental Fate Maps from Somatic Mutations
Marshall Horwitz, MD, PhD, UW Pathology
iPS cells from prostate cancer-associated stromal cells
Alvin Liu, PhD, UW Urology
Potential Therapies for Muscular Dystrophy
Morayma Reyes, MD, PhD, UW Pathology
Targeted Insertion of a "Floxed" Reporter in Human Embryonic Stem Cells by Zinc-finger Nuclease
Jay Gantz, Graduate Student, UW Bioengineering -- Poster Abstract
Neuralized iPSCs can migrate to gliomas: MRI findings
Tyler McKay, Research Technologist, UW Radiology -- Poster Abstract
10:45 – 12:05 Session 2
Stem cell-based replacement therapy for diabetes
Vincenzo Cirulli, MD, PhD, UW Medicine/Metabolism & Pharmacology
Embryonic Stem Cell-Derived Hepatocytes
Ed Kelly, PhD, UW Pharmaceutics
Update on the "in which" Case: Sherley v. Sebelius
Michael Corn, JD, UW Office of Sponsored Programs
Inducing Stages of Pluripotency
David Hockenbery, MD, UW Medicine/Gastroenterology & Fred Hutchinson Cancer Research Center
12:05 – 12:55 Lunch and Posters
12:55 – 1:55 Keynote Presentation
A Chemical Approach to Cellular Reprogramming
Sheng Ding, PhD
Associate Professor
The Scripps Research Institute
1:55 – 3:25 Session 3
Gene Targeting in Stem Cells
David Russell, MD, PhD, UW Medicine/Hematology & Biochemistry
Reprogramming iPS Cells as a Strategy for Correcting the Stem Cell Defect in Congenital Amegakaryocytic Thrombocytopenia (CAMT)
Neil Josephson, MD, UW Medicine/Hematology
Canine ESC/iPSC: apparent species specific challanges?
Aravind Ramakrishnan, MD, Fred Hutchinson Cancer Research Center
3:40 – 5:10 Session 4
HIF function in stem cell metabolism and iPSC induction
Hannele Ruohola-Baker, PhD, UW Biochemistry
Homing endonucleases as tools for stem cell genome engineering
Andrew Scharenberg, MD, Seattle Children's Research Institute
Gene correction of induced pluripotent stem cells from patients with inherited marrow failure syndromes
Hongyan Du, MD, PhD, Fred Hutchinson Cancer Research Center
